Found: 16
Select item for more details and to access through your institution.
Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 7, p. 1, doi. 10.1371/journal.ppat.1005742
- By:
- Publication type:
- Article
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 3, p. 1, doi. 10.1371/journal.ppat.1005520
- By:
- Publication type:
- Article
LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays.
- Published in:
- BMC Immunology, 2011, v. 12, n. 1, p. 33, doi. 10.1186/1471-2172-12-33
- By:
- Publication type:
- Article
Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancester of CH235 lineage CD4bs broadly neutralizing antibodies.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 9, p. 1, doi. 10.1371/journal.ppat.1008026
- By:
- Publication type:
- Article
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies.
- Published in:
- PLoS Computational Biology, 2010, v. 6, n. 10, p. 1, doi. 10.1371/journal.pcbi.1000955
- By:
- Publication type:
- Article
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0075665
- By:
- Publication type:
- Article
International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0030963
- By:
- Publication type:
- Article
Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy.
- Published in:
- Scientific Reports, 2017, p. 46308, doi. 10.1038/srep46308
- By:
- Publication type:
- Article
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0180720
- By:
- Publication type:
- Article
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models.
- Published in:
- Virology Journal, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1743-422X-10-347
- By:
- Publication type:
- Article
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features.
- Published in:
- Retrovirology, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12977-021-00579-9
- By:
- Publication type:
- Article
Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
HIV-1 Envelope Glycan Modifications that Permit Neutralization by Germline-Reverted VRC01-Class Broadly Neutralizing Antibodies.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 11, p. 1, doi. 10.1371/journal.ppat.1007431
- By:
- Publication type:
- Article
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials.
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 3, p. 431, doi. 10.1093/infdis/jis367
- By:
- Publication type:
- Article